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1. INTRODUCTION.
The influence of serum on enzymes may be considered kinetically 
as falling into one of two categories: either the enzyme is in­
fluenced by virtue of serum also containing such enzyme - in which 
case an apparent acceleration is produced: or else the action is 
associated with an absence from serum of the enzyme in question, 
in which case the action is one of true acceleration or inhibition, 
as the case may be: the mere fact that serum accelerates or
inhibits an enzyme in itself constitutes incomplete evidence of 
the nature of its action. In a recent publication (1930) I have 
shown how failure to recognise this principle has already vitiated 
work done on the subject.
It is usually a simple matter to determine whether an apparent 
acceleration is due to the presence of the enzyme in serum, or 
whether* the acceleration is a true one; greater discrimination 
however is necessary to establish the presence of both factors if 
present simultaneously in a case of acceleration, and to determine 
to what extent each is responsible for the effect observed.
Serum Enzymes, In some instances the action of serum Is wholly 
explained by the presence of a serum enzyme , as in the case of 
serum diastase; in other cases the action is only partially 
explained by the presence of an enzyme In serum, an example of 
which is human serum acting on lipase.
The enzymes recorded in serum include protease, ereptase, 
diastase, lipase, catalase, invertase, and maltase. It is Important 
to recognise that the distribution of enzymes in sjBrum is by no
means identical in different species.
Thus, while diastase is fairly widespread, occurring in man, 
sheep, cow, rat, and guinea-pig, it is absent from rabbit 
(according to Luers & Albrecht, 1926, whose findings I have not 
attempted to confirm). Lipase I have also found in man, sheep, 
cow, rat and guinea-pig. Maltase was not found in guinea-pig 
serum (Blacklock, Gordon & Pine 1930) but has been recorded in 
pig serum. Invertase I have failed to find in a number of 
animals, including man, but under experimental conditions (e.g. 
following intra-peritoneal injections of a commercial preparation 
of invertase) I have found it in guinea-pig serum, where it 
persisted for over 30 hours in one instance (Pine, 1930).
The influence of serum on enzymes not ascribable to the presence 
of serum enzyme. It is this category of the influence of serum 
on enzymes that is the subject of the present paper.
When serum influences an enzyme without itself containing 
this enzyme, then the influence is either one of true acceleration 
or of inhibition. Even when serum does contain an enzyme, its 
action may be greater than is to be accounted for by the presence 
of the enzyme: for example, human serum will increase the
activity of lipase to a degree exceeding what would be expected by 
the mere addition of a lipase of the strength of serum lipase.
The total acceleration is in this case partly due to the presence 
of serum lipase (apparent acceleration), and partly is a true 
acceleration.
It has been customary to explain the effect of acceleration 
by serum as due to Han accelerator,” and the effect of inhibition 
as due to an ttinhibitor,w or, more commonly, an lfanti-enzyme*.
In a recent study of ”enzyme-accelerators in serum,”however, I 
have shown (1930) that in the case of invertase the influence 
exerted by serum was entirely a function of pg, the serum acting 
as an accelerator over certain ranges of pH, and as an inhibitor 
over others.
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The one certain conclusion to be drawn from these experiments 
is that as far as invertase■is concerned serum contains neither 
accelerator nor anti-enzyme, but simply exerts a variable influence 
not due to specific substances present, but rather to specific 
physical conditions, such as those of pg, whose variations determine 
the final behaviour of the serum.
In the following pages I have brought together evidence both 
from my own experiments, and from the work of others, which 
justifies the conclusion that what holds good for influence of 
serum on invertase holds good for its influence on most other 
enzymes also: that is to say, true acceleration or inhibition by 
serum is not due to specific accelerators or anti-enzymes, but to 
various physical conditions such as pg. Pjj however is not the 
only factor of importance: in the mechanism of enzyme-inhibition 
the adsorption of the enzyme by serum may play the most important 
part, as in the case of the antitryptic action of serum.
In the previous publication referred to (1950) I have already- 
dealt with the enzyme-accelerating properties of serum, and there 
pointed out that serum has been known to accelerate only two 
enzymes - invertase and lipase. The same serum which accelerates 
invertase will also inhibit it if the pn is suitably altered.
The influence of pg Qn the lipase-accelerating power of serum 
has not been worked out; possible pH may not so completely deter­
mine the action of serum on lipase as on invertase.
In the ensuing part of this paper I have confined myself to
an examination of the present state of our knowledge of serum as an
inhibitor of enzymes. I have however given special consideration
to serum antitrypsin, and have found it necessary, before arriving
at a conclusion as to its nature, to consider in some detail its
properties, its relation to other organic antitryptic bodies, and
its variations in clinical and experimental conditions. This
detailed examination of serum antitrypsin is justified because of 
its importance clinically, because of the inaccurate ideas still
held generally as to its nature - the result of insufficient
5-
acquaintance with its properties: and finally, because I have been 
able to throw new light, to however modest an extent, on its 
mechanism.
2. THE ORIGIN AND SIGNIFICANCE OF THE TERM 11 ANT I "ENZYME”.
The first observation of the phenomenon of enzyme-inhibition by 
serum was made by Hildebrandt (1893)> who discovered that serum 
inhibited the action of emulsin. Hahn (1897) followed with the 
observation that serum inhibited trypsin, and Morgenroth (1899) 
found that it inhibited rennin.
Although none of these workers isolated any substances from 
serum which might account for the inhibition observed, they all 
explained the phenomenon observed by the presence of corresoonding 
anti-enzymes in normal serum, and adopting the language of 
immunology termed these hypothetical substances anti-emulsin, 
antitrypsin, and antirennin respectively. The assumption under­
lying this terminology - namely that serum contains substances 
capable of specifically neutralising enzymes in a manner analogous 
to the neutralisation of toxins by antitoxins - has lead to a 
great mass of research which in the main has failed to justify 
the assumption. Very early, Landsteiner (1900) showed, and 
Cathcart (19oip) and others confirmed, that trypsin inhibition 
was a property of the albumin fraction of serum rather than of 
the globulin fraction, whereas it was well established that the 
immunological antibodies resided in the globulin fraction.
Furthermore, while opinion differed as to the power of serum 
to increase its inhibition of an enzyme following injections of 
the enzyme no one could demonstrate a material increase of the 
enzyme-inhibiting action of serum following enzyme injections.
The consensus of opinion appears to be that trypsin is the only 
enzyme that can evoke the response of an increased enzyme-inhibition 
in serum, and even so, the increase never exceeds three or four 
times the original amount of inhibition. Such response is to 
be sharply differentiated from the effects of toxin injection on 
antibody formation in serum: true antibodies can invariably
k-
develop to the amount of thousands of times the original antibody 
content.
So reluctant have certain workers been to relinquish the 
antibody theory of enzyme-inhibition by serum that an endeavour 
has been made to explain the limited rise in trypsin-inhibition 
(antitrypsin) following trypsin injections by suggesting that 
the accumulation of antitrypsin rapidly produces an anti- 
antitrypsin as a defence against paralysis of protein metabolism. 
Although such an explanation is theoretically adequate, there is 
actually as little evidence of the existence of this alleged 
substance anti-antitrypsin as of the existence of the chemical 
entity "antitrypsin” whose limitations it was invented to explain.
At various times eminent physiologists have endeavoured to 
expose the fallacy underlying the current conception of anti­
enzymes. Weil (1910) pointed out that while serum can inhibit 
the haemolytic action of saponin, it does not necessarily follow 
that serum contains an anti-saponin. Bayliss (1919) in W-s 
characteristic manner pointed out that if a substance which inhibits 
an enzyme is entitled to be called an anti-enzyme, then HaOH is 
anti-pepsin.
3. THE ACTION OF SERUM ON ENZYMES IS LARGELY A FUNCTION OF ph
As Wells pointed out (1925) much work on enzymes has been 
utterly invalidated by the failure of the worker to regulate the 
PH of his enzyme mixtures. As is well recognised, enzymes are 
very sensitive to pH changes, and although they may retain 
activity over a fairly wide range of p h , quantitative studies are 
quite valueless unless the pg is fixed throughout the investiga­
tions .
The earlier workers seem to have quite ignored this principle. 
Bayliss (1912) in examining the evidence for Hildebrandt’s anti- 
emulsin found that the mere addition of serum to an emulsin 
mixture sufficiently altered the pg to produce a corresponding 
fall in activity of the emulsin.
5.
Bensley & Harvey (1912) showed that the absence of free HC1 in 
the cells of the gastric mucose formed the best protection 
against the secreted pepsin; in other words, the ph of the cell 
substance was in itself a quite adequate "antipeosin11. Dragsted 
& Vaughan (192l|) sewed the spleen and kidney into openings made 
in the stomach wall, and found that they were unaffected by the 
consequent exposure to pepsin, provided the blood supply were 
kept intact. In their view the mechanism of this immunity was 
not the presence of "anti-pepsin" in the exposed organs, but 
simply the buffer action of the blood and the absczption of the 
HC1 and pepsin into the blood stream. Thaysen (1915) found 
that "antirennetw could also be accounted for by the change in 
PH when serum is added to a rennet mixture; he also found that 
adsorption of rennet by the serum proteins played an additional 
part.
a
The danger of postulating a definite chemical entity to
account for a given property of serum is uniquely illustrated in
the results of a study I recently made (1930) of the properties j
of the invertase-accelerator of serum reported by Blackloek, •
guinea-nig
Gordon & Fine (1950). I examined the behaviouaT of/serum to 
invertase solutions adjusted to different values of ph, shd 
found that while serum accelerated invertase at the optimum pH 
of the latter (3 & at PH 5 the action was nil, and at pH 6 
there was a definite inhibition; at ph 7 & 8 serum accelerated 
again.
This behaviour of serum might be explained by saying that 
the invertase-accelerator has an inhibitory action at certain 
values of pH . It would however be equally logical to infer 
that an inhibitor was present which could accelerate at certain 
values of p h : sheep serum, in fact, behaves more as an 
inhibitor than as an accelerator. It might even be Inferred 
that serum contains both accelerator and inhibitor, each 
acting only at certain ph values.
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All these hypotheses, however, are essentially unsatisfactory 
oecause they involve the assumption that influence of serum on an 
enzyme is necessarily due to a definite chemical substance - 
an invidious assumption for which no evidence has been offered 
by the army of workers reporting serum anti-enzymes to almost 
every enzyme known.
When the importance of ph in relation to enzymes is fully 
recognised, it will be found that in many instances the mechan­
ism whereby the body reacts to an excessive formation of any 
enzyme is not by the development of a hypothetical anti-enzyme 
but by the local development of a pH unfavourable to the 
enzyme in question.
This mechanism undoubtedly accounts for the absence of 
peptic digestion of the stomach wall: no serum or tissue "anti­
pepsin" need be invoked.
In the case of other enzymes however the Influence of serum 
under different conditions of pn has not hitherto been worked 
out, and although ph regulation must play some part, It is prob­
able that a number of factors are involved in the defence of the 
organism against the action of excessive amounts of enzyme. 
Excretion is one of the chief factors, as in the case of amylase: 
destruction in the body probably occurs in the case of invertase, 
which I failed to recover from the urine during experiments 
In which invertase was injected in doses so large that it was 
found in serum; adsorption by tissue or serum proteins in the 
case of trypsin.
In vivo and in vitro action. The evidence available clearly 
shows that each enzyme is dealt with in an individual manner 
by the animal bod^yone or more factors being employed to check 
excessive enzyme action.
A careful examination of the evidence has left little
doubt in my mind that the conception of "anti-enzymes" as 
chemical antibodies should be replaced by that of "an enzyme- 
regulating mechanism" in v/hich excretion, adsorption, ph
regulation and actual destruction play a part.
A distinction must be clearly made between the action of
serum on an enzyme in vitro and the fate of the enzyme when
injected in the body: in the latter case, although the action
of serum may be the same as it is in vitro, the fate of the
enzyme is not necessarily related to this action, since in the 
body there are other influences besides that of serum in play.
Ip. ON t! ANT I-ENZYMES” REPORTED IN SERUM.
At various times serum has been reported to possess an inhib­
itory action towards trypsin, pepsin, rennin, papain, "autolytic . 
enzymes”, lipase, amylase, invertase, laccase, catalase, 
tyrosinase, emulsin, urease and fibrin ferment.
This action was stated to be either normally present, or 
if not, could be elicited by injections of the corresponding 
enzymes.
The following table, showing the optimum pn of the above 
enzymes, is of considerable importance in interpreting the ,#
phenomena recorded.
It would follow almost a priori that the addition of serum 
which has a pH of 7.1p5 would greatly reduce the activity of 
active but unbuffered solutions of pepsin, rennin, papain,
autolytic enzymes, emulsin,/invertase. Even invertase, which 
is accelerated by serum when buffered at its optimum ph, is totally 
inhibited, as I more recently observed, when serum isnadded to
Enzyme 
Trypsin (pancreatic) 
Pepsin (gastric) 
Rennin 
Papain 
Autolytic 
Lipase (duodenal)
a ( oavklim \
Optimum ph
*
5
5
ip.5
8.5
(serum) 8 -  8 .6
Amylase (pancreatic) 
Invertase (yeast) 
Laccase 
Catalase
Tyrosinase (potato)
Emulsin
Urease
6.5 - 8 
7
and
8 .
an active but unbuffered solution of invertase. In fact, a 
worker who did not protect his enzyme mixtures against change of 
pH (by using buffer solutions) would inevitably find that most 
enzymes were inhibited by serum, provided the optimum pH of the 
enzyme were not the pH of the serum.
The generally admitted discouraging effect that serum 
exerts on unbuffered or insufficiently buffered enzymes is in some 
cases to be sufficiently explained by the pH changes produced by 
the serum. In the case of trypsin however this.factor does not 
anoear to play any part. The influence of serum on trypsin stands 
apart from its action on most other enzymes, since, as I will 
show presently, the inhibition of trypsin by serum is purely 
a manifestation of the power of serum to adsorb the enzyme. 
Occupying an intermediate position between pepsin on the one hand 
and trypsin on the other, there is a group of enzymes,of which 
rennin is an example, whose inhibition by serum is partly a pn 
effect and partly ah adsorption effect.
I will now proceed to examine briefly the evidence hitherto 
adduced of the existence in serum of substances inhibiting the 
enzymes above mentioned.
(1) Inhibition of pepsin. The evidence already submitted seems 
to clearly show that the inhibiting action of serum is here 
entirely a function of pg.
(2) Inhibition of rennin. This was first shown by Morgenroth 
(1899) an& later by Czapek. The former claims that anti- 
rennin is greatly increased following rennin injections.
Eisner (19)9) did n°k find serum to have an inhibitory action 
on rennin, but he appears to have been equally unsuccessful 
with pepsin. Korschun (1902) suggested that rennin is 
inhibited by the formation in serum of "zymoid*1, i.e. a 
substance which, resembles the enzyme in being able to combine
with the substrate, but is unable to hydrolyse it. Certain
enzymes (e.g. trypsin} when heated to certain temperatures
become zymoids. Bayliss (19olf) and Bearn & Cramer (1907) showed
this for trypsin. If rennin injections were followed by the
formation in serum of rennin zymoid, the latter would produce
the effect of an,fantirennin” by "deviating” the caseinogen
subsequently
in any mixture containing rennet, so that there would be no 
available substrate for rennin to act upon. Korschun’s theory, 
however plausible, has not been proved experimentally. Fuld 
& Spiro (1900) found rennin inhibition in horse serum 
associated with the pseudo-globulin fraction: This observation 
justifies the conclusion of Thaysen (1915), who attributed 
rennet-inhibition by serum partly to adsorption of rennin by 
serum proteins; partly also to ph change induced on adding 
serum to a rennin mixture. Hedin (1911) does not consider the 
inhMtion of rennin by serum to be due to a true antibody. He 
found that injections of rennin did produce a rise in rennin- 
inhibition by serum, but a greater rise was obtained following 
injections of zymogen added to an actively rennin-inhibiting 
serum. If rennin injections produced antibodies to rennin, 
it is improbable that the injection of those antibodies would 
produce more "antirennin” than would the rennin itself.
Thaysen's conclusions seem to most adequately account for the 
behaviour of serum to rennin.
Inhibition of autolysis. Baer & Loeb (1905) and H.G.Wells 
(1906) early showed that serum retarded autolytic changes. 
Although autolysis is a well-defined phenomenon, there does not 
seem any advantage in accounting for it by a special set of 
enzymes solely concerned in it. The action of serum on autolys- 
ing tissue is merely the sum of its actions on the individual 
enzymes present in the tissues - notably proteolytic. It has 
not been shown, for example, that serum discourages any amylol- 
ytic or lipolytic changes incidental to autolysis, or that 
in fact any special action takes place beyond the normal protease 
inhibiting action of serum, which is discussed later.
10.
(^4-) Inhibition of emulsin. This was the first phenomenon of 
enzyme-inhi ition by serum to be resorted (Hildebrandt, 1893).
Ohta (1915) found that this inhibition was increased following 
emulsin injections. Abderhalden and Wertheimer (1922) however, in 
an important series of experiments dealing ’with the antigenic 
properties of a number of enzymes, failed to confirm this.
The optimum pg of emulsin (i+.Ij.) renders it probably that the 
action of serum is essentially due to its pH - a view taken by 
Bayliss (1912) after a critical examination of the work of 
Hildebrandt.
(5) Inhibition of other enzymes. Although amylase, lipase, 
and catalase are known to occur constantly in most sera, they 
fluctuate in value, and these fluctuations have been considered
by some workers as evidence of the existence of corresponding
n be considered to _ ...
anti-enzymes, which would then^vary inversely with the enzyme:
such a view has little following, and has even less evidence
to support it.
It is well known clinically that a rise in serum amylase 
is followed by a great increase in urinary amylase, the fluctua­
tions of which can be readily correlated with the variations 
of serum amylase.
It must be mentioned however that rabbit serum, which, 
according to Luers & Albrecht (1926) contains no amylase, has 
been rendered anti-amylolytic by these workers by means of amy­
lase injections.
On the other hand, Abderhalden & Wertheimer (1922) failed 
to obtain anti-enzymatic serum following injections of amylase, 
lipase, catalase emulsin, invertase, phenolase, urease, 1
tyrosinase, laccase, and fibrin ferment.
Bach & Engelhardt (192^) have described the inhibition 
of laccase by serum. Weil (1910) showed that papain is 
inhibited by serum as readily as is trypsin. 1
Among others, Blacklock, Gordon & Pine (1950) observed 
the inhibition of tyrosinase by serum: They failed to increase
11.
.4
the inhibition by tyrosinase injections, or to produce any - 
significant variation in serum amylase by repeated injections 
j of that enzyme. l_ln no instance has a body been isolated from 
serum to account for the inhibition of an enzyme. Most workers 
seemed to have automatically inferred the presence of an 
"anti-enzyme” on finding that the addition of serum retarded 
an enzyme. The result is that a system of nomenclature has 
grown up around the action of serum on enzymes which is 
unfortunate in that it implies quite unproved assumotions as 
to the nature of this action. Such terms as anti-rennin, 
anti-tyrosinase, etc. - which are now common currency - imoly 
two unproved and inaccurate ideas; namely that definite sub­
stances are present, and that they are of the nature of 
specific antibodies of the Ehrlich type. Although therefore 
these terms are misleading if interpreted immunologically, 
and although their use might with advantage be dispensed with 
generally, yet as a shorthand descriotion they are sometimes 
useful, particularly in the case of so well established a term 
as serum antitrypsin. In using the latter term, as I shall 
have occasion to do - faute de mieux - none of the unwarranted 
implications referred to are Intended.
5. ORGANIC TRYPSIN INHIBITORS.
Following Hahnfs observation (1897) that serum "contained 
antitryosin", i.e., retarded the action of trypsin, many substances 
of organic nature were examined for their influence on trypsin, in 
the hope of some light being thrown on the phenomenon. It was 
soon found ^ that very many substances possessing diverse properties 
inhibited trypsin, and if Hahn*s example were to be followed, it 
would become necessary to postulate not a few different antitrypsins.
The following Is a list of substances of organic nature, which 
have been reported to inhibit trypsin.
(1) Serum (Hahn, 1897). The properties of serum in relation to 
its inhibition of trypsin will be discussed later.
12.
(2) Worm Extract. Welnland (1903) and Dastre & Stassano (1903) 
reported that extract of intestinal worms effectively inhibited 
tryptic action. Dastre (1903) first made the interesting 
observation that in proteolytic mixtures to which worm extract 
is added, the trypsin gradually recovers and finally acts as
if quite unimpaired. He inferred that the inhibiting 
principle of worm extract is gradually destroyed. This 
behaviour of worm extract is identical with that of serum.
Hamill (1906) more fully worked out the oroperties of 
worm extract in relation to its inhioition of trypsin. He 
found that
a) boiling the extract in neutral or acid solution had 
no effect on its power to inhibit trypsin.
b) boiling in alkaline solution destroyed this action.
c) on dialysis the inhibiting property could be recovered 
from the dialysate only. The inhibiting principle 
appeared to be a crystalloid.
d) the inhibiting principle was soluble in alcohol of 
less than 85% strength only.
Prom these facts it is quite evident that the causes of 
trypsin-inhibit ion by worm extract and by serum are not 
identical.
Boiling and dialysis have different effects on serum, 
although the Dastre phenomenon is common to both. *
Hamill1s work suggests that a definite crystalloid 
substance Is present as the inhibiting principle.
Burge (1915) believes that intestinal worms are protected 
from the host’s trypsin by absorbing and oxidising the latter 
in their own tissues.
The mechanism of worm extract however does not appear 
to be one of destruction but rather one of paralysis of trypsin.
(3) Egg-white. Vernon (190i|.) first showed that egg-white 
was antitryptic, and this has been repeatedly confirmed, by 
Sugi^oto (1915) anc* others. Heating for 4 hr. at 70°C. * :
15.
was found destroyed the antitryptic property of egg-white.
By comparing the digestion of heated and unheated egg- 
white by trypsin, Bayliss (1923) found that egg-white showed the 
Dastre phenomenon, i.e., although little digestion took place in 
the first few hours in the digesting mixture containing 
unheated egg-white, this mixture showed a gradually increasing 
activity of its trypsin so that after I4.8 hrs. the amount of 
digestion was just as great as in the mixture containing heated 
egg-white. I have frequently elicited this phenomenon for 
egg-white, and in fig. 1 it is illustrated in a curve based on 
one of my experiments.
Considering the chemical and physical similarities between 
egg-white and serum, as well as the effect of heat and the 
presence of the Dastre phenomenon, it is highly probable that 
the cause of trypsin-inhibition is the same in both substances.
Bacteria. Czapek (1903) first observed that bacteria 
resisted tryptic digestion, and Jobling (191J+)^investigating 
the mechanism of this resistance found that boiling did not 
affect it in the case of gram positive organisms, and only 
slightly impaired It in gram negative ones. He also showed that 
bacteria lose this resistance when extracted with chloroform, 
and came to the conclusion that the phenomenon was due to a 
lipoidal envelope around the bacteria.
Yoast. Buchner & Haehn (1910) found that the endotryptase 
of yeast did not hydrolyse certain substrates, such as gelatin 
and casein: according to these workers, this inaction was due 
to "yeast antitrypsin" a substance which adsorbed or combined 
with the substrates, and so rendered them unavailable to the 
enzyme. This mechanism, if true, is virtually a zymoid one, 
and not analogous to that of Inhibition tof serum.
Animal tissues and secretions. Levene & Stookey (1903) 
found that body tissues generally were antitryptic. Blum & Fuld
(1906) found antitryptic properties in the cells of the gastric 
mucosa: Langenskiold (19lij.) confirmed this, having previously
(1907) found similar properties in mucous secretion. Czapek
(1905) found that erythrocytes were antitryptic.
Dochez (1909) reported the absence of antitryptic 
properties in cerebrospinal fluid and the fluids of serous 
cavities generally, except when these fluids contained in­
flammatory exudate. Ooie (1905) had previously noted the 
antitryptic action of inflammatory exudates.
Von Schoenbom (1910) found urine antitryptic under 
certain pathological conditions, but Fujimoto (1918) found 
this property in normal urine. Normal urine, however, loses 
its action if heated at 100°0 for \ hr. but not at a lower 
temperature (Fujimoto), and this stability sharply 
differentiates the antitryptic action of urine from that of 
serum. It is probably however that tissues as well as 
exudates containing plasma act in the same way as serum.
(7) Unsaturated fatty acids. Jobling (19llj.)Wfirst showed 
that the caseous material from tubercular tissue was highly 
antitryptic and adduced evidence to show that this was due 
to the unsaturated fatty acid content of the material, in 
a series of investigations ("Studies on Ferment 'action* 1912-15) 
into the antitryptic action of serum he showed many similar­
ities between it and the action of unsaturated lipoids, 
and concluded that such lipoids were responsible for the 
behaviour of serum to trypsin. Joblingfs theory, which has 
received much prominence in America, where it is regarded by 
many as the true explanation of the action of serum, is 
quite inconsistent with the essential properties of serum as 
an antitryptic substance. The theory will be discussed more 
fully later on, but I would observe here that to prove two 
substances identical it is essential to show that all and not 
merely some of their properties are identical. After showing 
that unsaturated fatty acids ceased to be antitryptic after 
saturation Jbbling found that both serum and unsaturated 
fatty acids lost their antitryptic properties on treatment
15.
with iodine or potassium iodide..
He inferred that the unsaturated lipoids of serum became 
saturated with a consequent loss of antitryptic action.
Although it is admitted that the antitryptic action 
of serum and unsaturated fatty acids resemble in a number of 
ways, there are several divergencies not to e ignored - 
outstandingly two;
(a) The action of serum is destroyed.by heating for J hr. 
at 70OC: unsaturated fatty acids resist such treatment.
(b) Trypsin gradually recovers from the inhibiting 
action of serum in a manner similar to that of egg-white
or worm extract: the kinetics of inhibition by unsaturated 
fatty acids is totally different, as I will show.later.
(8) Lecithin. Schwartz (1909) shov/ed that Lecithin could 
restore the antitryptic action of serum lost by extracting 
with ether.
THE PROPERTIES OF SERUM ANTITRYPSIN.
(1) Methods employed in estimating antitryptic action. At 
least six different methods have been used by various workers 
to determine antitryptic action; They have in the main given 
concordant results.
(a) Puld & Gross method. This was one of the first 
employed (1907) for the purpose. It consists of adding 
to a number of tubes (about six) equal quantities of 
casein and of the serum tested. Increasing quantities of 
a standard solution of trypsin are then added to the 
tubes which are shaken and incubated for a given time 
(a few hours). At the end of the period of incubation 
equal amounts of dilute acetic acid are added to all 
tubes. A coagulum will appear in all tubes containing 
imcompletely digested casein. The tube without a 
coagulum containing the least amount of trypsin is 
noted, and the antitrypsin index of the serum is
expressed interms of the amount of trypsin in that tube: 
the minimum amount of trypsin being so chosen that it 
will lust digest the casein in the given time.
This method has the disadvantage of being rather 
cumbersome - involving the use of a large number of tubes: 
it is obviously not very sensitive.
(b) Method of Folin & Dennis (1P11). Jobling soon gave 
up the Fuld & Gross method for this one, which, like 
those following, is more adapted to refined quantitative 
measurement of antitryptic activity. Here two tubes 
containing equal quantities of trypsin and casein 
solution are incubated: to the first is added a certain 
volume of serum, and to the second an equal volume of 
water. After a given period the incoagulable nitrogen is 
estimated in the two tubes, and the difference between the 
two values divided by the second value - expressed as a 
percentage - gives the antitryptic index of the serum.
Young (lPl8) also used this method in his researches.
(c) Viscometric method. This was first used by Feldstein 
& Weil (1P08), and more recently by (VDonovan & Davison 
(1927). It is based on the fact that when gelatin is 
hydrolysed by trypsin the viscosity of the mixture falls 
in proportion to the amount of tryptic action. Although 
Weil writes highly of this method, the application of 
physical changes to the measurement of chemical changes
is not very satisfactory. Using t M e method, 0fDonovan & 
Davison failed to demonstrate the presence of amylase In 
human serum, although such demonstration is unequivocal by" 
any chemical method.
(d) Electro conductivity method. Bayliss strongly 
advocated this method, which is based on the increase ill 
the electrical conductivity of a protein solution when 
the protein molecule is split up into amino acids.
(e) Refractometrlc method.
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Brailsford Robertson fl91f?
first used this method in his study of the kinetics 
of antitrypsin. It is based on the increase in 
refractive index of a casein solution in x.roportion to 
its conversion into amino acids. The measurements made 
are those of refractive index.
(f) Sorensen^ titration. All the foregoing methods 
are subject to the criticism that when two digesting 
mixtures are compared, one containing serum and the 
other containing an equal amount of water, but otherwise 
the same in composition - then the amount of protein 
in the two tubes is not the same, and therefore the 
amount of digestion not strictly comparable; for it 
must be remembered that serum is a 9% protein solution. 
The technique I have used and found highly satisfactory 
has been as follows:
Two tubes were prepared containing equal quantities 
of trypsin, buffer (pH 8) and serum: in the first,
the serum had been heated at 70OC for ^ hr. to destroy 
antitryptic action; in the second the serum was 
Untreated.
. An aliquot portion of each tube was titrated by
Sorensenfs method immediately the constituents were
added and mixed, and a fixed number of hours later.
The rise in acidity indicated the amount of tryptic
action that had taken place in the two tubes containing
the same concentration of trypsin and substrate.
If the rise in acidity in the first tube * A, and the
A - B
rise in the second • B, then the ratio A expressed as 
or as a fraction of unity 
a percentage/adequately measures the antitryptic
activity.
One of the chief advantages of the Sorensen method 
is the additional information it gives when the free 
and formol acidities are considered separately.
The effect of Dialysis. Gathcart (I90I4.) showed that on
dialysing serum the residue only is antitryutic. This was 
confirmed by Meyer (I909), Stavraky Fujimoto (1918),
and others.
The reverse holds true for worm extract, the dialysate of 
which is antitryptic.
(3) Effect of drying. This does not affect the antitryotic 
oroperties of serum, as was early shown by Chapman (1905). Dried
serum, it was further shown by Cobliner (1910) did not lose its
antitryptic action when shaken uo with chloroform, although
undr.ied serum is rendered much less antitryptic by such treatment.
(i-k) Effect of shaking. Fujimoto (1918) found that shaking 
did not diminish the antitryptic action of serum.
(5) The association of the various protein fractions with
antitryptic action. Landsteiner (1900) was the first to
observe that the precipitate formed on full stauration of serum
with ammonium sulphate is highly antitryotic, and concluded the
albumin fraction was the seat of antitryptic action in serum.
This was confirmed by Cathcart (190I4-), Opie Sc Barker (1907)
and Muller (1908). Other workers, while agreeing that the
albumin fraction was the principle source of antitryptic action,
also found the globulin fraction to be antitryptic: these are
the findings of Doblin (1909/9 Kammerer (1911 ) Kammerer Sc
Anbry (1°13) and Fujimoto (1918). Glassner (1903) found anti­
trypsin to reside in the euglobulin.
(6) The effect of heat. That heating at 70°C for J hr. will 
destroy the antitryptic action of serum has been well established 
since the work of Vandevelde (1909)> Meyer (1909/9 Jobllng 
(I91I4.) and others. Fujimoto (1918) has shown that there is a 
slight variation in the temperatures at which the sera of 
different animals must be exposed to destroy antitryptic action*
This influence of heat is characteristic of serum, and is 
not shown by either worm extract or by unsaturated fatty acids* 
Jobling (191I4.) attempts to overcome this objection to his theory 
by showing that although unsaturated fatty acids do not lose their 
antitryptic action on heating, they do lose this property when 1
ij
heated together with serum, at 0^o C for 4 hr. nevertheless, j|
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as he admits, the iodine value of the mixture does not fall 
on heating, and therefore the loss of antitryptic action is not 
due to saturation of the fatty acids. Further, he states 
that the unheated mixture of serum and unsaturated fatty acid 
is less antitryptic than either 6f its constituents. Hence 
the loss of antitryotic action is not necessarily produced by 
heat, being initiated in the cold and merely accelerated by 
heat. Joblingfs experiments therefore do not reconcile the 
action of heat on unsaturated fatty acids with that on serum.
(7)* The action of chloroform and ether. Delezenne & Pozerski 
(1903) first showed that serum loses much of its antitryptic 
action when shaken up with chloroform. Cobliner (1910) 
noting that there is no such loss when dried serum is used 
concluded that the lipoids of serum are not the source of anti­
tryptic action.
Kirchheim (1915) and- Jobling (19lip/31 confirmed the 
observations of Delezenne & Pozerski.
Jobling was unable to entirely destroy the antitryptic 
action of serum by shaking up with chloroform and incubating 
for some time.
In experiments carried out with serum and egg-white I 
obtained in both cases marked reduction - but not entire 
suppression - of antitryptic action (fig* 2 ).
Schwartz (I900 ), Sugimoto (1013)> and Jobling (I91UH*) 
found that ether acted in a similar manner to chloroform.
(8 ) The action of oxidising agents. Jobling .(lPlll-/^showed 
that wheft iodine, potassium iodide or HjO^acted on serum,
the latter lost in antitryptic activity. H© showed that I
unsaturated lipoids were affected in the same way, and used 
this observation to argue that unsaturated lipoids were ,>
\ . .1%. .. ■ • / p
the responsible substances in serum. \
(9) The action of colloids. Jobling showed that serum 
ceased to be antitryptic after shaking up with kftoldtl,
starch, agar, or a bacterial emulsion. The mechanism of
this action, it is generally agreed, is one of adsorption
of certain constituents of serum by the colloid added.
According to Jobling these constituents are the lipoids.
It is due to Jobling (1915 }fc)that the Abderhalden
reaction has been shown to be due to the same principle
of adsorption of the trypsin-inhibiting substance in serum
by the introduced placenta. Very few workers now hold the
original viev; of Abderhalden that this reaction is due to
a specif ic; enzyme •
Jobling further found that the above-mentioned colloids
acted in a similar manner in vivo. An injection of kaolin
for example, was followed by a great fall in serum antitrypsin
together with symptoms closely resembling anaphylaxis. He
was able to throw some light on the latter condition by such
experiments, and formed the opinion that anaphylaxis was
brought about by the adsorption of the circulating serum
antitrypsin (lipoids, in his view)by the second dose of
'
protein: in this way the increased trypsin provoked by the 
first dose of protein was free to act on the circulating 
blood proteins and produce highly toxic products of 
hydrolysis."
(10) The Dastre phenomenon. I am applying this name to 
the phenomenon of an enzyme recovering in time from the 
action of an inhibiting substance, since it was Dastre who. 
first showed (1903) that worm extract had an evanescent 
inhibiting action on trypsin. Egg-white also presents this 
phenomenon, as was shown by Bayliss (1923), and as I have 
repeatedly demonstrated myself.
The fact that serum behaved in a similar manner to 
egg-white was first suggested by the work of Kirchheim (19^5) 
who demonstrated that serum merely prolonged the action of 
trypsin. Previously, (Bayliss Sc Starling, 1905, and 
Hedin, 1909) it had been shown that the action of serum on i
■ ■ " b/ . £
trypsin was not one of destruction, but one of paralysis* j
using the Sorensen method and the technique I have out­
lined I was able to follow the course of digestion of serum- 
orotein by trypsin, and in this way not only obtained the 
Dastre effect with serum, but found that almost invariably 
the recovery of the trypsin from inhibition was such that the 
inhibited trypsin ultimately showed greater activity than 
the trypsin acting freely on heated serum.
The experiments showing this recovery were carried out as 
follows:
Two tubes were incubated whose contents were as below -
Tube 1 Tube 2
Trypsin ,2 cc .2 cc
Serum .1 cc .l^finactivated)
Buffer
PH 8 ..7 cc .7 cc
(a) The source of trypsin was liquor trypsin co.
(Benger’s) and before use it was neutralised with NaOH
•/ 10
to pjj 8 and then further diluted to 50% of original
strength.
(b) The buffer was prepared according to Clark & Lubs 
tables.
(c) The serum in Tube 2 was inactivated by heating at 
70oc for \ hr. It was heated together with the buffer so 
as to avoid the difficulty of mixing afterwards: during 
the heating the tube was stoppered to avoid loss of volume 
by evaporation.
(d) After tube 2 was cooled, the trypsin was added to the 
two tubes from which, after adequate mixing, .1 cc was 
immediately withdrawn for titration of acidity with g NaOH
Too
A layer of toluol was added to the tubes before incubating.
The method of titration was that employed by 
Wigglesworth (1927) in his investigation on cockroach 
protease.
The pipetted fluid (.1 cc) was added to 5 cc 
distilled water In a test tube of standard size: 5 drops 
phenolphthalein solution (.05%in 50^ ethyl alcohol)
were added, and N  NaOH added from a 2 cc micro burette.
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graduated in hundredths of a cc. The alkali was added until 
a pink colour developed identical with that of a tube(of 
similar make) containing 5 ccs buffer solution of pH 9 plus 
5 drops .05%-phenolphthalein in 5rfjt alcohol. The end 
point was remarkably sharp.
The figure thus obtained was a measure of the "free 
acid” present: the "formol acid" was obtained by adding 
.5 cc 5 0 neutralised formalin (ph 8) and titrating further 
with alkali till the end point was reached again. When 
'" desired the free and formol acids were combined in a single 
figure, - the "total acid.”
Determinations of the acid present in .1 cc of the 
incubated mixtures were carried out from time to time, and in 
this way curves of digestion were plotted.
Pig. 3 is the curve of a typical experiment, showing 
how the initial inhibition of trypsin is finally replaced 
by accelerated digestion more active than in the tube 
where trypsin was not initially inhibited. An analysis of 
fig. 3> form of separate curves of free and of formol
acid formation (figs. Ij. & 5) throw some light on the 
phenomenon. The latter figures show that the final 
superior digestion of unheated serum applies only to formol 
acid formation: on no occasion have I found more free acid
ultimately formed in the presence of unheated serum (tube 1) 
than of heated serum (tube 2), whereas formol acid formation 
was almost invariably greater in tube 1 than in tube 2, 
provided digestion was sufficiently prolonged.
In some cases, even after weeks of incubation, the 
total acid in tube 1 remained below the value in tube 2.
An example of this type of incomplete recovery is shown 
in fig. 6, the curve of which was obtained from the serum 
of a guinea-pig which 7 days previously had received a 
large injection of liquor trypsin co. An analysis of the ^
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total acid curve, in figs. 7 & 8, shows that the incomplete­
ness of recovery of the trypsin affects only the free acid 
formation, the formol acid curves intersecting in the same 
way as in fig. 5.
Pigs. 9, 10, and 11 are the total^free and^formol acid 
curves of digesting mixtures containing
10 gelatin .5 cc
trypsin 50%n««N*) .5 cc
Buffer pg 8,5 .5 cc
Serum .2 cc
Saline .88 .3 cc
Here also the greater digestion of unheated serum affects
the formol acid curve only. The addition of the gelatin
appears to hasten the recovery of the trypsin.
Interpretation of foregoing results.
(a) It would appear on examining fig. 3 that serum 
can not only retard the action of trypsin, hut can
at a later stage enhance it, after passing through an 
intermediate stage during which trypsin becomes gradually 
released from its bonds. In the fig. 6 type of experi­
ment the stage of enhancement is not reached, though 
the trypsin has recovered considerably from the inhib­
iting action of serum.
(b) An examination of the free and formol acid curves 
separately shows very strikingly that .the transition
fr om inhibition to enhancement applies only to the formol 
acid formation; the extent of formation of free acid with 
unheated serum never exceeds that with heated serum 
although, provided digestion is sufficiently prolonged 
and the trypsin is fairly active, the same amount of 
free acid is finally produced in the two tubes: fig. 7 
shows a marked but not complete free acid recovery in 
the unheated serum tube*
(c) Serum therefore possesses the property, destroyed by 
heat, of temporarily retarding free and formol acid 
formation by trypsin, and„subsequently accelerating formol,
acid formation only.
How is this behaviour of serum to be explained?
The explanation would prove a difficult natter if it be 
assumed that pancreatic trypsin, • hich is the basis of 
the commercial preparation used (Liquor tryosin Go.) is 
a pure enzyme. There is much evidence, however, in favour 
of the view that the trypsin of pancreatic secretion is 
essentially a mixture of two enzymes- tryptase breaking • 
proteins down to polypeptides and increasing the free 
acidity of the digest, and ereptase, hydrolysing the 
polypeptides to amino-acids and producing a rise in formol 
acidity.
If this view is correct, the behaviour of serum 
becomes more easy to explain. It does not exert its action 
against trypsin as a whole, but only against the tryptase 
portion of it. The inhibition of tryptase will, by pre­
venting the liberation from the proteins of a suitable 
substrate for ereptase (i.e. polypeptides), produce an 
apparent inhibition of ereptase. There does not, however, 
appear to be any necessity for assuming that the initial 
depression of formol acid formation is due to an anti- 
ereptase action of serum rather than to a shortage of sub­
strate consequent on tryptase inhibition. On recovering 
from the inhibition, tryptasejwill produce polypeptides on
which ereptase will a c t flut why should formol acid pro­
duction in the unheated serum tubes exceed that in the 
heated tubes? There are two possible explanations. Serum 
contains either an ereptase or an ereptase-accelerator.
The most likely explanation is the existence of a serum 
ereptase, which has been reported by various workers, 
including Jobling (1912) who reports that serum ereptase is 
destroyed by heating at 70°C and (1915)^that “serum ereptase^ 
is not influenced by antitrypsin”. Hence, when tryptase 
has recovered from the inhibition by serum, the ereptase 
of the unheated serum will reinforce the ereptase of the
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ereptase of the pancreatic trypsin, and so produce formol 
acid at a rate which will outstrip the formol acid produc­
tion in the tube containing heated serum (where pancreatic 
ereptase acts alone, the serum ereptase being destroyed by 
heat).
(d) In a word, the behaviour of serum to pancreatic trypsin 
can be explained by the presence of two factors, firstly, 
an anti-tryptase factor, and secondly, ereptase.
This conclusion is of some importance for at least two 
reasons. In the first place the evidence justifying it 
confirms in a novel yet definite manner the dual nature of 
trypsin; secondly, this evidence, by showing that it is 
against the tryptase portion only (the portion forming free 
acid) that serum directs its inhibition, and not against 
the ereptase moitie (the portion forming formol acid) - 
by showing this, it directs serious criticism against those 
methods of measuring “antitrypsin” which estimate toegther 
the products of both tfcyptase and of ereptase action. The 
methods thus open to criticism include those of Bayliss, 
(electrometric), and Robertson (refractometric) though not 
of Polin (incoagulated N). The error Involved will depend 
on the period of incubation used as well as the strength 
of serum ereptase present: the extent of the error will be 
appreciated in the following example:
Course of digestion of heated and unheated sera.
After 8 hrs.incub. 27£ hrs. ~95
__ F ’P o r  T______ , F For ~ T For . 7
Unheated ser. .05 *o6 *09 *15 •-L9 *52 .23~3±1 • 51#.
heated sera. .22 .10 .32 .27 .17 - W  .27 .28 .55
F - Free acid.
For - Formol acid.
T - total acid
Figures are cc acid in .1 cc Incubated fluid.
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It will be readily seen that there is a considerable 
discrepancy between the degree of inhibition as measured from 
the free acid and that measured from the total acid.
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/> inhibition (or wantitryptic Index")
In 8 hrs. in 27i^  hrs. In 95 hr s.
Prom free acid figs. 52 15
fl total n M 72 27 - 16 *
*(i.e. 16%  acceleration')
The methods criticised will therefore give too low a value 
for the index of inhibition.
(11) The kinetics of serum antitrypsin.
(a) The kinetics of recovery.
The Dastre phenomenon was by no means elicited by all 
proteolytic mixtures containing serum: it was only obtained 
when the concentration of serum was suitably adjusted to 
the concentration of trypsin. On the other hand, it was 
found that:(l) v/hen the concentration of tryrsin was greatly 
in excess in relation to the serum the serum failed to 
produce any appreciable inhibition. (2) 'Then the concentra­
tion of serum was greatly in excess in relation to the 
trypsin, the latter completely failed to recover from the 
inhibition. The correlation of the relative trypsin- 
serum concentration with the manifestation of the Dastre 
phenomenon is illustrated by fig. 12. The curves were 
obtained by plotting the digestion of a series of tubes 
containing. (i). trypsin in concentrations from 20 %  
to 2 °f of the commercial preparation, (2) sheep serum in 
Constant concentration of 10®^ , and (3) buffed, pH8* A 
pair of tubes was put up at each concentration of trypsin, 
one containing unheated serum (tube 1), the other heated 
(tube 2): each point on the curve was obtained by express­
ing as a percentage the ratio
total acid in tube 2 - total acid in tube 1 
total acid in tube 2
which expresses the degree of inhibition by the unheated
serum. The total acid figures were taken because in this
case the value of serum ereptase was practically nil, so
-i
that the error involved in including forsiel acid did not 
affect the nature of the curves obtained,
although it would affect the accuracy of the individual 
antitryptic indexes.
An examination of fig. 12 shows that (1) in concentra­
tions of l^and less trypsin is completely inhibited and does 
not recover from the inhibition even after 23 days. (2) be­
tween l|y£and 20% trypsin is only partially inhibited and 
recovers to an extent proportional to its concentration.
(3) At 20% recovery is ultimately complete.
From the nature of the curves it would be reasonable 
to infer that concentrated trypsin completely resists the 
inhibiting action of serum (dotted lines in fig. 12).
Hence serum can influence trypsin in essentially three 
ways according to the relative concentration of serum and 
trypsin: weak trypsin is permanently inhibited: trypsin of 
intermediate strength is temporarily inhibited: strong 
trypsin is probably not inhibited.
From the continuous nature of the curves it would appear 
likely that the action of serum is essentially the same at 
all concentrations of trypsin,varying in degree only, and 
that therefore the apparently permanent inhibition of weak 
trypsin is not due to destruction of the trypsin, any more 
than is the temporary inhibition of stronger trypsin.
(b) The work of Hedin. Hedin, who frankly regarded serum 
as containing an antibody to trypsin, made an important 
contribution to the study of the kinetics of his antibody
(1906). He found that (1) a small amount of serum had a 
relatively greater effect on trypsin than a large amount,
(2) it was impossible to completely neutralise a given 
solution of trypsin by adding any amount of serum. This 
result is confirmed by Young (1918) whose results are 
illustrated in fig. 13: this curve shows that excess of 
serum has no effect on the residual activity of trypsin.
Hedin thus shows .that a mixtue of trypsin and excess 
serum possesses both antitryptic and tryptic action, jUe?#
trypsin and antitrypsin can co-exist when the latter is in 
excess, each exerting a definite action on added substrate 
or enzyme respectively in spite of the other. In discussing 
the adequacy of Ehrlich’s toxin-antitoxin mechanism to 
explain the trypsin-antitrypsin reaction ITedin states ”the 
fact that on further addition of antibody the fluid may contain 
free trypsin and free antibody at the same, time this 
theory does not account for, unless one assumes that trypsin 
is made up of different c^ondituerftsTI (page i_j_82).
It is evident from this statement that Hedin considered 
the possibility of trypsin being composed of at least two 
enzymes, one of which was uninfluenced by serum. *'y own 
experiments showing that serum antagonises tryptase, but 
not ereptase, peculiarly bear out Hedin»s suggestion.
I have not however been able to confirm the common 
findings of Hedin & Young that excess serum will not 
entirely inhibit a given amount of trypsin. Fig. 12 shows 
that lj.% and 2f trypsin were completely inhibited by 10% 
serum. The cause of the discrepancy is difficult to explain, 
but may be due to the difference in the methods employed in 
studying the kinetics of serum. Hedin and Young combined 
fairly concentrated trypsin in constant amount with increasing 
amounts of serum: hence all flasks contained a fairly active 
ereptase together with a large excess of casein added as 
substrate. Casein, it is stated by Jobling (1915X^(p* 152) 
is an exception to the rule that ereptase does not split 
proteins: furthermore, ereptase la uninfluenced by the anti- 
ferment (Jo bling).
(c) Analogy with charcoal. To Hedin is also due the discovery 
that charcoal inhibits trypsin in a manner kinetically very 
similar to that &f serum. Thus the amount of trypsin bound by 
charcoal follows the same law as the binding of trypsin by 
serum: small amountscf charcoal bind relatively more trypsin 
than larger amounts.
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This relationship, which can he expressed by the
equation x * ky11 (where x - amount of tryosin bound, and
y » amount of active charcoal), is a logarithmic one, and is
readily accounted for by assuming that the mode of action
of charcoal is one of adsorption of the trypsin. Hence
Hedin on the basis of kinetic similarity concluded that serum
also inhibited trypsin by the process of adsorption.
further
The behaviour of charcoal throws some/light on the 
adsorptive process. Hedin showed that although a filtered 
trypsin solution after treatment with excess charcoal was 
quite inactive, yet an unfiltered trypsin-charcoal mixture 
incubated with casein was definitely and invariably active, 
though most of the trypsin remained inhibited. Hedin con­
cluded that in the presence of substrate subsequently added^ 
charcoal did not retain all the trypsin adsorbed, a small 
portion of it being taken up by the casein. In a similar 
manner might be explained the impossibility of totally inhib­
iting a solution of trypsin by means of serum, although it 
is impossible to actually demonstrate the similarity since 
trypsin cannot be Removed with its inhibitor in a
trypsin-serum mixture, in the simple manner possible with 
charcoal•
(d) Robertson*s formula. Brailsford Robertson (1918) 
using the refractometric method, examined quantitatively the 
inhibition of trypsin by serum and arrived at the formula
- T  - C 
A(,l-T)
where T * fraction of trypsin inhibited 
A • concentration of serum present
C * a constant representing the antitryptic value of 
the serum used. Robertson claimed that his constant was an 
absolute measure of the inhibiting power of serum, being 
independent of the concentration of serum used. An examina­
tion of his results, however, shows that the fraction T
a (1-¥)
tends to be constant only for mixtures containing more 
concentrated serum {lo% to 3 % )  and even then the variation
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in C is too considerable (5.87 to 6.95 for a single serum) 
to oermit of the value of C being used as a characteristic 
figure for the inhibiting power of serum.
Where approximate results only are required, however,
the constant is a useful expression of antitryptic power,N
and sufficiently accurate, provided the concentration of
serum in the mixture is not too dilute. By this method
Hansen (1918) was able to show that injections of trypsin ’
had no influence on the protein quotient of serum
(globulin1. although the antitryotic index (as measured by albumin j
C) rose to three times the normal value.
(©) The specificity of the inhibiting action of serum.
Von Eisler (1905) found that human serum did not inhibit 
human pancreatic trypsin any more than it inhibited pig 
trypsin, while Weil (1910) found that serum actively 
inhibited the vegetable protease papain. Serum, it would 
follow, does not exert any biologically specific action 
on trypsin, but inhibits all proteases alike. Apparent 
specificity may be shown by serum nevertheless as the 
work of Young (1918) proves.
He found that whereas dilute serum equally inhibited 
two samples of equally active trypsin obtained from the 
same source, the inhibition was different when the concen­
tration of serum was increased. Pig. llj. illustrates this 
result, and fig. 15 shows the result of another of YoungTs 
experiments in which equally active samples of fresh and 
commercial trypsin are compared.
Young was unable to account for the preferential 
action shown by serum for certain trypsins, though this 
preference was not’ shown in all the experiments carried 
out: he did show, however, that the presence o f #
could not account for the phenomenon. „ .
His findings ara important in showing 
attributing all variation in antitryptic action to
serum alone without first determining the uniformity of the 
trypsin solutions used: Young believes that much work on
antitrypsin must be invalidated by this variability of trynsins
of equal activity but different source when incubated vith 
similar sera
THE INFLUENCE ON SERUM OF INJECTIONS OF TRYPSIN.
(1) The controversy. There is a sharp division of opinion as to
whether injections of trypsin will give rise to an increased power
of serum to inhi it trypsin.
Achalme (1901) was the first to investigate the matter, and
found a definite increase in the antitryptic power of serum following
injections of trypsin. In this he was confirmed by Von Berman & 
Jochman & Kantarovitch (1908)
Bamberg (1908) / Meyer (1909)1) Jobling, Peter sen & Eggstein (1915)?*>
Hansen (1918), and Rlacklock, Gordon h Fine (1930). On the other hand
negative results were obtained by Landsteiner (190?), Doblin U 909W
Rosenthal (1910), 7/eil (1910) and Young (1918). Pozerskl (1909)
also found no response to injections of papain.
There is similar disagreement as to the influence of injections
of tissue substances other than prepared trypsin. Thus Miller (I909)
found that the injection of a mass of leucocytes (containing leuko-
protease) led to a rise in antitryptic power of serum, though the rise
was preceded by a fall to below normal. Braunstein & Kepinov (1910)
confirmed this result using various tissue emulsions. Halpern (1911)
injected pancreatic tissue from a dog into dogs with a similar
result. Kepinov (192I4.) also obtained a rise in antitryptic value
serum of guinea-pig following intrfcperitoneal injections of liver.
(1911)
Arise was also observed by Meyer /to follow oral administration of 
t&yreoid.
On the other hand Bradley (1910) questions these results for 
leueo-protease, and Rosenow & Farber*(191U) report that no rise in 
Antitryptic index followed Injections of Thorium X, although con­
siderable destruction of leucocytes, with presumable liberation of 
■^QUcoprotease, occurred.
A careful examination of the properties of serum antitrypsin
and of the various methods employed in measuring its value has 
led me to the conclusion that the failure of workers to obtain 
a rise in antitryptic value of serum following injections of trypsir 
could adequately be accounted for by one or more of the following 
circumstances.
(a) The antitryptic power of serum is not constant in value, 
but follows a swinging course which in the normal animal is 
often determined by definite physiological conditions. Thus 
Jobling found a definite rise following a few hours after a 
meal, a result which I have confirmed.
(b) It is generally agreed that the variations in antitryptic 
value are not very great, and even after injections of trypsin 
the rise in index by workers who did obtain a rise was com­
paratively slight. In Hansen's experiments the rise never 
exceeded three times the normal index. Consequently, if the 
serum was antitryptically at its peak, an injection of trypsin 
would fail to produce a further rise in index.
(c) Hansen records that when the index returns to normal 
after a rise due to a trypsin injection, further repeated 
injections fail to produce a second rise. It is probable 
that such a refractory condition of serum might arise from 
other conditions - physiological ones - than the results of 
trypsin injections.
(d) The choice of method has a very important effect on 
the results obtained. Elsewhere I have shown (Pine, 1930) 
how the use of the viscometric method applied to amylase- 
estimation led certain workers to conclude that serum does not 
contain amylase, although serum-amylase has invariably been 
detected by chemical methods. Weil, who failed to find a 
rise in index following trypsin injections, also used the 
physical method of viscometry for estimating tryptic action, 
and this must be taken to discount from the validity of his 
results: enzyme action is, after all, finally a chemical 
process, and enzyme activity should strictly be measured by j
analysis of the resulting products. This being granted, 
purely physical methods will then possess a validity in nro- 
portion to their yielding results in agreement with chemical 
methods.
In methods where casein is used as a substrate another 
source of error is liable to arise, since casein can serve 
as a suitable substrate for serum ereptase, according to 
Jobling. Thus variations in serum ereptase will superimpose 
themselves on variations in antitrypsin, the nature of the 
latter changes being thus disguised or even distorted.
It seems to me therefore that there are so many reasons 
why a rise in antitryptic index following a trypsin injection 
might not be elicited, that a failure to obtain such a rise is 
only of significance as showing that under certain circum­
stances (serum taken without definite relationship to food; 
injections made when serum is at an antitryptic peak^ or in an 
unresponsive condition following an abnormal rise) and by the 
use of certain methods of uncertain reliability a rise in index 
is not elicited. On the other hand the demonstration of a 
rise in antitryptic index after an injection of trypsin - 
provided the rise is outside the limits of normal variation - 
is sufficient evidence that the serum is antitryptically 
responsive to trypsin injections, even though response is 
not invariable.
(2) Experimental demonstration of the rise in antitryptic index 
following injections of trypsin.
The results of experiments carried out with ttoe guinea-pigs 
are graphically represented in figs. l6, 17, and 18.
The method of obtaining the antitryptic index may be considered 
open to criticism since, in the technique employed (already 
described in a previous section) the substrate used is the serttm 
itself, and must therefore vary with each specimen taltan: 
secondly, it may be objected that since substrate is hot present 
ib excess, the extent of hydrolysis in 2lj. hrs cannot be considered
as representing the activity of the enzyme present.
I would answer these objections as follows:-
(a) The index is calculated from the ratio of digestion of. 
a given amount of serum-protein to the digestion of the 
same amount but in the absence of any inhibition. Actually 
ofcourse the index is the difference between this ratio
and unity. Hence the actual amount of protein present is 
not of consequence provided it does not vary greatly from 
speciment to specimen: in practice the variation was not 
found to be great.
(b) It is true that the acidity measured is not a true 
measure of the activity of enzyme present: it must be 
realised, however, that in the method used it is not the 
activity of the inhibited enzyme that is measured, but 
the extent to which it has in a given time recovered from 
the inhibiting action, this degree of recovery being 
directly related to the degree of inhibition.
An important advantage of the method used is the 
possibility by Serensen*s method to distinguish between 
the free acid and formol acid produced; since the formation 
of free acid only is opposed by serum, the index is in all 
cases calculated with reference to free acid formation 
only.
The three guinea-pigs experimented on were kept under
«
observation for over a month: in each case there was a 
gap of lip days during which, as can be seen, no examina­
tions were made owing to an interruption in the investi­
gation.
to any extent 
Guinea-pig T did not respond/to the first injection
of 1 cc trypsin (Bengerfs), but rose within a few hours
of a second injection of 2 cc, and remained high for
some time. After a month it was swinging considerably,
with a tendency to rise, which a third injection of 1 cc
maintained.
35. ,
Yore orolonged observations of T might have been desirable.
Guinea-pig U demonstrated in definitely unequivocal 
fashion the rise in index in response to an injection of 1 cc 
trypsin. The rise was maintained even after 20 days, a second 
injection having no observable effect.
Guinea-pig V also responded to a first injection, although 
the rise was here preceded by a definite fall in index, 
accompanied by symptoms of collapse (immobility of many hours 
duration).
In 17 days the index had returned to a lower level, and
again responded to an injection (of half the first dose): the
rise was maintained for a week. A fall in index immediately
following a large injection of trypsin seemed to be associated
with symptoms of collapse. Thus guinea-pig Q, following an
injection of 2.5 cc trypsin, became immobile: and although
recovery set in in 20 minutes, the index fell from .6 to .if in
5 hours, and death ensued in 22 hours. In this case the
trypsin was not neutralised, though in all other cases it
was brought to a ph of 8.3 before injection; the route in all
cases was intraperitoneal. It will be seen that although
guinea-pigs T, U & V responded similarly to adequate injections
of trypsin, they differed in their subsequent condition, T
tending to remain high, but swinging, U remaining persistently
high, while V tended to return to normal in a few days.
(3) Formation of precipitins and Immune bodies.
Pozerski (1909) obtained both precipitin and immune body, but 
action
Bo anti-enzyme^following injections of papain. Gontacuzene &
Jonescu (1909) obtained analogous results with pepsin. Young, who 
failed to obtain an increase in serum antitrypsin following trypsin 
Ejections, was unable to demonstrate the formation of a precipitin. , 
f These results strongly suggest that the antibodies formed in 
*®sponse to enzyme injections are the results of the protein 
lapurities associated with the enzymes, the latter in themselves 
$oing incapable of giving rise to true immunity reactions.
8. CLINICAL VARIATIONS IN SERUM ANTITRYPSIN.
•Many hopes were early entertained that the antitryotic index 
could be utilised as a test for various clinical conditions, but it 
soon became clear that numerous conditions, both physiological and 
pathological could give rise to the same kind of variation.
(1) Physiological variations.
(a) In fasting. The antitryotic index is always dimin­
ished, as was shown first by Rosenthal (lplo), and later 
by Franz & Jarisch (1912). Jobling Petersen & Eggstein 
(1915)0)found that in starvation the serum antitrypsin 
(rabbit) fell continuously, rising again for a short period 
on the ninth day, and then falling sharply till death 
occurred on the 13th day.
(b) After food. The same workers showed that after food 
the value of serum antitrypsin rose above normalfjoW»>u»
My own observations are confined to one experiment with 
a guinea-pig which had an index of .59 before feeding 
(7.30 a.m.) and .78 after feeding (3 p.m.) The following 
day the index was .78 after feeding (9.30 a.m.) (In all 
cases guinea-pigs breakfast at 8 a.m. daily.)
(c) Effect of weaning. Rheuss (1909) found an increase 
in the serum antitrypsin of infants when breast feeding
i was replaced by artificial feeding.
I
(d) Pregnancy and puerperium. Becker (1909) found an 
increase in labour and early puerperium, but not in preg­
nancy. Grafenberg (1909) and Franz (1911-1.) however
| obtained an increased index in pregnancy, while Ecalle (1917)
found that the increase commenced in the fourth month of
pregnancy and continued till the second week of the
puerperium.
(e) Relation to leucocytosls. Most workers find that the 
antitryptic index of serum follows a course parallel to the 
leucocyte count. This is the common conclusion of Bittorf
(1907), Wiens (1907$  Landois (1909)* Wiens & Schlect (1909)
Waelli (1912). Jurgensen (19H )  failed to confirm this relationship 
Since leucocytes contain a fairly active protease, a leuco- 
cytos— is, if associated with a proportionate destruction of 
leucocytes, will produce an effect equivalent to an injection of 
trypsin into the blood - i.e. a rise in index. Since the rise 
in index following an injection of tryosin is sometimes preceded 
by a fall, it might be expected that a sharp Increase in the 
leucocyte count would cause an initial fall in index. Thus 
Jochman (1906) found that in myeloid leukemia, when a sudden 
flooding of the circulation v/ith myelocytes took place, the 
antitryptic index fell considerably, in some cases the serum 
becoming tryptic.
(2) Pathological Variations.
Conditions where the index is increased.
The majority of pathological conditions with an altered index 
come under this category, and of these the greater number are 
definitely associated v/ith wasting: for this reason the term
Jcachexia reaction*1 has been applied to a heightened index in a 
•lasting disease.
(a ) Carcinoma♦ An increased index in 95% of cases of cancer was 
Increased index in cancer was also found by Von Bergman & Meyer (1908)* 
r found by Brieber & Trebing (1908)./| Jolla (1909), Hort (1909),
I.andois (1909) and Waelli (1912) confirmed the presence of the
? "cachexia reaction" in cancer.
£
Weil (1910) points out that although a raised index cannot 
an
be considered as/important test for cancer, yet so constant is 
this high index that its absence may be taken as a valid reason 
for excluding a diagnosis of cancer where uncertainty exists.
(b) Sarcoma. This form of malignant disease is also associated 
with a raised index, as has been shown by Breber & Trebing and 
by Waelli: the latter found the increase in index less marked 
than in carcinoma.
(c). Tuberculosis. The above workers found this condition 
also marked by a raised index to a very constant degree.
(d) Exophthalmic Goitre. Waelli found the index increased in 
this condition.
(0 ) Anaemia. Brisker & Trebing, Brenner (1909), and Grafenberg 
found the index increased in the 'rore severe forms of anaemia, 
while Grafenberg found this increase in chlorosis also.
(f) Trauma. Zunz & Gwerts (1918) found a rise in index follow­
ing traumatic injuries.
Conditions where the index is diminished.
(a) Poisoning from chloroform, phosphorus or iodine (Onie,
Barker, and Dochez 1919)*
(b) Post-anaphylactic shock (Pfeiffer & Jarisch).
(c) Septic conditions. (Wiens, 1907)4?
In pneumonia the index rises from the commencement of the 
pyrexia until the crisis, vhen the index sharply falls, and 
after a second lesser rise assumes a normal level. (Jobling, 
Petersen, Eggstein, 1915$  in this condition therefore the fall 
in index is associated with a fall In temperature.
13) The application to diagnosis of the influence of serum on enzymes.
The variations of serum antitrypsin represent only one, and 
irhaps the least useful phase of such applications; its usefulness 
|uld no doubt be enhanced by a greater knov/ledge of the normal 
iriations, as well as of the exact nature of the action of -serum 
)trypsin. Comparatively little success has attended the use of any 
|ber enzyme test for serum. Thus the variations of serum diastase 
to of little significance apart from the very marked increase 
Itociated with acute pancreatic disease.
Serum lipase variations have also been claimed to be of service 
.^'diagnostic purposes. Thus Buchler (192i^ ) states that normal serum 
Pase is destroyed by quinine, while lipase derived from liver or 
tissue is quinine-stable; he was thus able to determine whether 
various psychotic conditions there occurred any disintegration of 
*«r or nerve tissue, since, when such disintegration occurred, there 
.Pa&red in serum a quinine-dtable lipase in addition to the normal 
ine-susceptible lipase.
In this case use is made not of variation in strength of 
serum lipase, but of variation in properties, and this latter 
seems to me a much more fertile source of exploitation for 
diagnostic purposes.
On the whole it might be said that little diagnostic 
service has been rendered by the study of variations of individ­
ual enzymes or enzyme factors in serum. Thus (1) serum anti­
trypsin is increased in many conditions besides cancer, although 
the constancy of increase in cancer is very high: (2) the lipase 
accelerating action of serum is much depressed in cancer (Lewis 
& Corran, 1928), but there is little information as to the 
condition of the serum in other casting diseases.
Nevertheless the presence of both increased antitryptic 
action and diminished lipase-accelerating action is not likely 
to recur in other diseases with the same frequency as either 
of these changes considered individually.
It seems to me that the study of variations (qualitative
as well as quantitative) in serum enzymes and in the enzyme 
(i.e. "accelerators" and "inhibitors") 
factors of serum^might yield much more fruitful results diag-
nostically if the variations were correlated over a sufficiently
wide range of factors. In this way characteristic "enzyme
pictures" of serum might be found to exist In many pathological
conditions which at present have only been shown to yield
definite but uncharacteristic variations.
THE NATURE OF SERUM ANTITRYPSIN.
There are two questions it is necessary to answer if the nature 
pt serum antitrypsin is to be known; firstly, what is the substance 
to serum responsible for the inhibition of trypsin? Secondly, what
Tv
!« the mode of action of this substance on trypsin?
(1) The antitryptic substance. The three main theories as to 
the identify of the antitryptic su stance are described below, 
and their relative merits then discussed: the antibody theory 
is treated as a variation of the protein theory.
(a) Amino acid theory. Bayliss first shov/ed (I90I4.) that the end 
products of tryptic action retard the action of trypsin: 
Abderhalden & Gigon (190?) confirmed that trypsin was retarded
by amino acids. On the strength of such observations Rosenthal 
(IPIO) suggested that serum antitrypsin owed its action to the 
amino-acid content of serum, ’-//alters (1912) pointed out that 
the action of amino acids is too slight to account for the 
behaviour of serum.
Pore recently Hussey & Northrop (1923) suggested that the 
polypeptides formed by tryptic action are the source of serum 
inhibition.
No serious proof has been offered for either of these 
theories, and the occurrence of the Dastre phenomenon contradicts 
them emphatically: end products of tryotic action cannot reason­
ably account for an antitryptic action vfich is at Its maximum at 
the commencement and progressively diminishes.
(b) Lipoid theory. Schwartz first shov/ed (1909) that extraction 
with ether lessened the antitryptic cower of serum, and considered 
this as proof that serum owed its antitryptic action to its
llpo id content. His findings were confirmed by Sugimoto (1913)*
and the lipoid theory in a modified form was strongly urged by
Jobling and his colleagues in a series of papers entitled
(otsto
"Studies in Ferment action". (191?4-)* Jobling submitted evidence 
shewing (1) that unsaturated fatty acids and soaps possessed 
definite antitryptic action* (2) that saturated fatty acids and 
soaps possess no such antitryptic action* (3) that the saturation 
of fatty acids or soaps by such means as KI, 1^, H^O^ leads to 
the loss of antitryptic action: similar treatment of serum leads 
to the loss of antitryptic action of serum. This is confirmed by 
Slovzov & Zenophonton (1919): (I)-) that although unsaturated 
soaps do not lose antitryptic action when heated alone, they do 
lose this action if heated at 70°C for | hr. in the presence of 
serum: (5) that the chloroform extract of serum - presumably 
containing the lipoids - will exert an antitryptic action if
saponified, although without this treatment the extract will
not exert such action.
A more careful scrutiny of JoblingTs experimental results, 
however, reveals the following facts:- (1) On no occasion Is 
there any record of an unsaturated lipoid exerting antitryptic 
action without previous saponification. After describing the 
formation of an antitryptic soap by the saponification of an 
ether extract of serum, Jobling states (p. Ip68) "it is not 
necessary to assume that they can act only as soaps; probably 
the esters containing unsaturated fatty acids are just as 
effective;" the probability, however, would have been greater had 
experimental evidence of it been offered. The importance of 
such evidence must have been clear to Jobling since he states 
(p. ii-75) that the lipoids which he considers as responsible for 
the antitryptic action of serum are present in the form of esters.
He does state that in unpublished experiments he found a
fine olein emulsion to possess "some ferment-inhibiting action";
but no further details are given. In all the scrum studies,
antitryptic action is expressed in terms of the action of soap
derived from serum.
in
(2) There is/jsufficient regard paid to the pg of the
enzyme mixtures; the practice described of making mixtures
"a little alkaline" with N_ NaOH creates a doubt as to the
10
uniformity of pg conditions throughout the experiments: this
practice certainly increases the danger of assuming with the
i
author that the serum esters are the source of antitryptic action 
on the ground that the "slightly alkaline" soaps prepared from 
the esters are antitryptic. (3) The attempt is made to bridge 
the gap between antitryptic lipoids and serum as regards the 
effect of heat by showing that unsaturated soaps do lose 
antitryptic power when heated in the presence of serum. From 
Jobling»s figures, however, It is clear that loss of anti­
tryptic power of the unsaturated soap takes place on mixing 
with serum in the cold, and that heat merely Increases the loss;
1*2.
acidity of the soap-serum mixture also increased the loss.
i« i ,,
Examination of Jo b l i n d s  Theory. Jobling states^ ( p . I l o O) that 
the discovery that sera when extracted v/ith chloroform soon lost 
their antitryptic action, convinced him ”that the ferment- 
inhibiting substrates of serum were lipoids, and that they were 
soluble in fat solvents”.
The fact that the chloroform extract, when freed from 
chloroform and re-added to the extracted serum, did not restore 
its antitryptic action was explained by the assumption that 
to restore such action it was necessary to restore not only 
the lipoids, but also their original state of dispersion of the 
lipoids in the serum.
This Jobling proceeded to do by saponifying the chloroform 
extract and rendering it slightly alkaline!
This saponified product which Jobling found to be antitryptic 
cannot legitimately be considered as equivalent ft&SBXbttsxx to 
the substance extracted from serum.
That the lipoids of serum have any connection with the anti­
tryptic action of the latter is contradicted by the work of 
Cobliner (1910) who found that dry serum retains its antitryptic 
action after extraction with chloroform or other fat solveftts.
Finally, I have shorn that the^iature of the inhibition 
produced by serum is essentially different from that produced 
by unsaturated soaps. Thei Initial effect of . 5 % sodium oleate 
is to stimulate trypsin, which after 21+ hours shows lessening of 
activity. Serum, on the other hand, initially exerts its 
maximum inhibition oh trypsin, which may ultimately recover 
completely.
This contrast is illustrated in fig. 19which represents 
one of several experiments carried out.
It would appear that Jobling, who has demonstrated anti­
tryptic properties in several substances such as the easebus 
material in tuberculosis and the envelopes of certain bacteria, 
felt under the necessity of proving that all such substances
contained identical tryosin-inhibitors. Actually, as I have 
shown, there are a number of different substances of organic 
origin possessing in common an antitryptic action*
(c) The Protein Theory. It has been definitely shown that 
the antitryptic action of serum is associated with the protein 
fraction (Landsteiner, 1900: Cathcart I90I4.S and others), the 
albumin fraction being more antitryptic than the globulin.
Fujimoto (1918) obtained crystallized albumin and found 
it to be highly antitryptic. He admitted the possibility of 
some other constituent of serum entering into the composition 
of the srystals however, and on a whole considered that the 
antitryptic action was due to the serum proteins and possibly 
some other undetermined factors in addition.
Oppenheirner (1913) came to the similar conclusion that 
serum antitrypsin was due to multiple causes, of which the 
^eculiar configuration of the protein molecule was one.
Oopenheiner & Aron, 1903)
(1920)
Teale & Bach/came to the conclusion that the nature of the 
serum proteins was the cause of the antitryptic action of serum.
Although the evidence on a whole is in favour of the 
serum proteins being the seat of antitryptic action, there has 
been a feeling among workers that some other factor is involved. 
This has been clearly shown by the work of Beaton (1922), who 
found that the antitryptic index May rise without any change in 
the albumin content of serum, and in some cases the rise may 
even be accompanied by a fall in serum albumin.
There is therefore some additional factor in the action 
of serum besides the presence of protein, and this factor is 
in all probability a physical one - namely the degree of 
dispersion of the proteins.
Mode of action of Proteins* The classical work of Hedin (190^) 
limed by Hata (1909), Bayliss (1923), Young (19I8 ) and others,
has shown that the mechanism of inhibition by serum is one of 
adsorption of trypsin-by the serum proteins. Such a mechanism is 
perfectly reconcilable with Beatonfs findings since the amount of 
adsorption depends not only on the amount of the adsorbing colloids, 
but also on their degree of dispersion. Thus the antitryptic index 
©f serum might increase without the concentration of proteins necess­
arily increasing, for the existing amount of circulating protein, by 
in Lncrease in its state of dispersion, can give rise to a greatly 
ncreased surface for adsorption and therefore a heightened capacity 
$ adsorb trypsin. It can be shown by a simple calculation that when 
Bay particle undergoes division into n smaller particles, the total 
lurface of the smaller particles is imes the surface of the
larent particle.^ Hence, if the degree of tryosin-inhibition can be 
ionsidered as directly proportional to the surface presented by the 
lolloidal particles of the serum protein, then the antitryptic index 
m  be doubled either by doubling the amount of protein without 
altering the average size of colloidal particle, or by the formation 
tf eight colloidal particles from each original one without altering 
total amount of circulating protein.
The mechanism of adsorption would also serve to explain one 
iportant difference between trypsin inhibition and the inhibition 
other enzymes by serum - namely the capacity of trypsin to ultl- 
tely recover from the inhioition, there being no such recovery 
fported for other enzymes. As Bayliss points out (1Q23), the 
sorbed trypsin is able to slowly attack the serum proteins adsorbing 
until the latter are entirely hydrolysed and the trypsin thus 
orated.
When another enzyme such as invertase is inhibited by serum 
a, on the assumption that the inhibition is also due to adsorption 
serum proteins, it would not be expected that recovery should take 
c©, since invertase would be unable to hydrolyse by enzyme action 
adsorbing bodies. In my own experiments with invertase I found 
t inhibition was not recovered from: thus an invertase solution 
unbuffered produced l0/£ inversion of 2 %f cane sugar in 2lj. hrs.
1*5
* See note accompanying Pig. 2o. „rv^
and 30^ inversion in 5 days, while with a similar unbuffered 
solution in the presence of 10% serum no inversion took place 
after 3 days.
Adsorption however is not a complete explanation of serum 
antitrypsin: since all enzymes before exerting their specific 
action must be adsorbed by their respective substrates it still 
remains to be explained why trypsin should be inhibited when It 
is adsorbed by serum proteins although It acts freely when 
adsorbed by other protein substrates.
Discussion of the antibody theory.
The study of the variations of serum antitrypsin in disease 
and experimentally led Wiens (1907^to the conclusion that it was 
of the same nature as the immunological antioodies formed by the 
body in response to antigens. Meyer (1909) supported this view 
on the ground that serum antitrypsin is increased by trypsin 
injections: in his view, and in that of Stavraky (I91I4.) normal 
serum antitrypsin is formed as a response to proteases liberated 
during the tissue destruction which normally takes place as a 
metabolic process.
Eisner (1909) believed antitrypsin was a true antibody 
because of its specificity - i.e. ttit inhibited trypsin only, 
and not rennet, pepsin, emulsin, or cobra lipase.* He evidently 
was not aware of the power of serum to inhibit other enzymes than 
trypsin.
The antibody theory, round which much controversy has raged, 
is not very illuminating because it refers the nature of serum 
antitrypsin to the nature of Ehrlict^s antibodies, whatever the
latter might be.
as seems probable
If/Ehrlich!s bodies are protein in nature, then this 
theory becomes a modification of the protein theory which is 
discussed above.
There is no doubt that klnetically the action of serum on 
trypsin resembles that of antiserum on toxin? in both cases the 
amount of serum required is not proportion—al to the amount of 
substance neutralised, the ratio of serum required increasing
very considerably as neutralisation of the substance is
approached.
The relationship is represented by a logarithmic curve such 
as satisfies the requirements of an adsorption phenomenon.
It may therefore be said that Immunological antibodies and 
serum antitrypsin resemble each other in that
(a) Both are protein bodies acting by means of adsorption
(b) They can be increased in amount by injections of the 
substances they antagonise.
(c) Both are normally present in serum.
On the other hand the following differences between them 
exist:
(a) Immune antibodies are associated with the globulin 
of serum: antitrypsin with the albumin chiefly.
(b) The injection of antigens can lead to increase of 
immune bodies to the extent of thousands of times the 
normal amount: whereas even an active response to trypsin 
injections will only treble the normal antitrypsin 
content.
(c) The immune antibodies are highly specific, an 
increased capacity to neutralise a particular toxin • 
being attended by a low neutralising power for other toxins 
there is never any marked variation in the power of serum 
to inhibit the various enzymes normally inhibited by it.
The antibody theory of trypsin therefore amounts to little
more than an expression of the fact that both antitoxic action 
and antitryptic action are both adsorption phenomena in which 
the adsorbing bodies are proteins.
CONCLUSIONS.
(1) Serum can influence an enzyme in thee ways:
(a) It may contain the same enzyme, by virtue of which 
an "apparent acceleration" is produced: examples of this
are human serum (which contains diastase) acting on diastase 
and guinea-pig serum (which contains lipase) acting on lipase.
(b) It may not contain the same enzyme, and therefore (1)
if it increases the activity of the enzyme, the action is one 
of "true acceleration," and (2) if it diminishes the activity 
of the enzyme the action is one of inhibition. The only 
example known of true acceleration by serum is its action on 
invertase at certain values of pp.
Examples of inhibition , on the other hand, are numerous, 
since most enzymes - with the exception of those present in 
normal serum (diastase, lipase, and catalase) are, to varying 
degrees, inhibited by serum.
(c) It may contain the same enzyme, yet increases the 
activity of the enzyme to a greater extent than can be 
accounted for by this fact. Here there is a "total acceleration 
consisting of "true" and "apparent" elements. The only 
example of this type of influence is the action of serum 
(human, cow and other animals, but not rat or guinea-pig) on 
lipase; such serum contains both lipase and "lipase’accelerator*
(2) The cause of true acceleration by serum, or at any rate ofie 
causey has been shown - in the case of invertase - to the the pjj 
of the final enzyme mixture: by suitable alteration of the pfi: the 
influence of serum can be changed from acceleration to inhibition
r The cause of lipase-acceleration has not been shown.
(3) The causes of enzyme inhibition by serum are essentially two, 
and they may sot together or separately. They are: (1) the pH 
change produced by addition of serum. This cause will operate in
.proportion as the pH of the serum (* 7*^5) 3-s removed from the 
 ^optimum ph of the enzyme.
Thus inhibition of pepsin by serum is entirely due to this 
, factor, while inhibition of rennin, papain, invertase, emulsin is 
partly due to pH and partly to the second factor, (2) adsorption.
I This factor is chiefly responsible for the inhibition of laecase,
|and tyrosinase, and solely responsible for the inhibition of trypsin.
(1+) The various influences of serum on enzymes- have early been 
attributed to definite but unspecified chemical substances, 
although the evidence of such entities was usually confied to the . 
more occurrence of the phenomena of acceleration or inhibition.
When inhibition was obtained it was customary to go further and. 
state that the entity was of the nature of an Ehrlich antibody.
In this way an ill-founded system of terminology arose in which the 
inhibiting action of serum was explained by the occurrence in 
serum of a system of anti-enzymes, such as anti-pepsin, anti­
trypsin, anti-rennin, anti-tyrosinase, etc.
This terminology arose at a time when little was known 
of the nature of the action of serum on enzymes, and when very 
few workers took any account of the oh of the5r enzyme mixtures.
(5) Other trypsin inhibitors of organic origin besides serum
are (1) Worm extract.
(2) Egg-white
(3) Bacteria 
(Ip) Yeast
(5) Animal tissue generally
(6) Inflammatory secretions 
(?) Unsaturated fatty acids.
(8) Lecithin.
An examination of the properties of these trypsin-inhibitors, 
while revealing varying degrees of similarity, establishes the 
essentially different nature of the inhibiting mechanism in 
serum, worm extract, yeast, bacteria and unsaturated fatty acids.
(6) Serum antitrypsin has the following essential properties:
(a) The property of inhibition is not lost on dialysis.
In this it differs from worm extract, the inhibiting principle 
of which is in the dialysate.,
(b) Heating at 70°C for i hr. destroys the property of 
inhibition. Unsaturated fatty acids and worm extract on the 
other hand, are unaffected by such treatment.
(c) Drying has no effect.
(d) Shaking has no effect. ,
(e) Mixing with CHCl^ diminishes antitryptic activity in 
proportion to.the time of contact. Ether is said to have a
similar effect.
(f) The addition of certain colloids (starch, gelatin, kaolin) 
diminishes the antitryptic activity.
(g) The antitryptic property is chiefly associated with the albu­
min fraction: the globulin fraction is also antitryptic.
(h) Serum exhibits the Dastre phenomenon, i.e. the inhibition 
of trypsin it causes is gradually recovered from. This 
phenomenon is also shown by egg albumin and worm extract.
Serum differs from these other inhibitors in that the 
may
inhibited trypsin^ultimately become; more active than the 
trypsin which was incubated with heated serum and which there­
fore was uninhibited.
An analysis of these results rendered possible by the 
Sorensen method of estimating tryptic activity, shows that the 
superior activity of inhibited tryosin applies only to the 
”formol acid11 produced, and not to the "free acid”, which never 
exceeds, though usually ultimately equals, the free acid 
formed by the uninhibited trypsin.
This is explained by the hypothesis that commercial trypsin 
consists of a tryptase portion (producing ”free acid”), and 
an ereptase portion (producing ttPormol acid”), and it is only 
against the tryptase that serum exerts its inhibiting action: 
as a consequence, when serum also contains ereptase, the 
latter reinforces the ereptase of the commercial trypsin, 
whereas uninhibited trypsin acting on the heated serum is not 
so reinforced since the heating of the serum also destroys 
the ereptase.
Thus the ultimate superior activity of inhibited trypsin is 
markedly evident with guinea-pig serum v/hich contains an active 
ereptase, but is not obtained with sheep serum, presumably owing 
to the absence of ereptase.
(i) A study of the kinetics of serum antitrypsin reveals (1) 
that the Dastre phenomenon is only shown when certain concen­
trations of serum act on certain concentrations of tryosin. In
the presence of a great excess of serum there is no recovery of 
tryosin. When trypsin is greatly in excess, inhibition is not 
obtained, or recovery is more rapid than can be detected. (2)
The amount of trynsin bound by increasing quantities of serum 
furnishes a logarithmic relationship identical with that obtained 
by the binding of trypsin by colloidal charcoal. (Work of 
Bedin). This relationship is explained by the assumption that 
the tm^ KMxlzdaxttlaxgixptaDKemxix&xscacmxx^ acmxSimodxtonxxac&xtixecxecxkantk 
ol£ xarocxftsKxat xo&xocodckxkdtalLxpcscxkicxkstscxiax x Jdst * xsc^ xtdxscKafcoata; xtoscit xfcbcx 
phenomenon of inhibition is due to adsorption of trypsin by the 
colloids of the serum.
(?) Injections of trypsin have been shown by most workers to produce 
I rise in the antitryptic power of serum. Failure to obtain such a 
result is explained by the following reasons:
(a) Unsatisfactory method used in estimating antitryptic power 
(e.g. viscometric method).
(b) Unsatisfactory technique (e.g. failure to control pn)
I (c) Serum is subject to normal fluctuations in antitryptic
index, a fact which must have a bearing on the results , since
(d) in any case the amplitude of variation of serum antitrypsin 
is not great, the maximum increase following injections of trypsin
■ never exceeding three or four times the normal value.
B  (e) Trypsin from different sources, although of the same 
1  activity, may be differently affected by the same serum. (Young). 
.tP) It has not been satisfactorily proved that any other enzyme than 
yypsin will, on injection into the body, give rise to increased anti- 
B*yae action. It has been shown however that orecipltins and 
Boceptors have been evoked by such injections, the antigens being the 
BRein associated with the enzyme.
;B) The chief clinical variations of antitrypsin are 
I (a) Physiological variations: the antitryptic index is decreased 
m  *s increased after feeding, after weaning, and in
■  the latter period of pregnancy and early puerperium. It runs 
B  parallel to the leucocyte count.
(b) Pathological variations.
It is increased in carcinoma, sarcoma, tuberculosis,
exophthalmic goitre, anaemia and trauma.
It is diminished in poisoning by CKClj, phosphorus, or
iodine, in shock following anaphylaxis and in septic conditions.
Evidently the application to diagnosis of variations of
antitryptic index is not promising: nevertheless, the correla-
other
tion of such variations with/enzyme changes in serum (such as 
the changes - quantitative and qualitative - in serum lipase) 
may produce ~ore characteristic pictures.
(10) The nature of the substance in serum responsible for the 
intitryptic action has been the subject of many theories, the most 
important of which are the following three:-
(a) Amino acid, or end product theory. This is evidently 
untenable since the antitryptic effect of serum is at a maxi­
mum at the beginning of its action, and diminishes progressively 
as the end products increase.
(b) pLiooid theory, (including unsaturated fatty acid theory 
of Jobling). Although lipoids and serum resemble in several 
ways in their inhibition of trypsin, serum lipoids cannot be 
held responsible for the action of serum for the following 
reasons:
(i) The effect of heating at 70°C for \ hr is to destroy 
the antitryptic property of serum whereas lipoids remain 
antitryptic even after boiling.
(ii) The modes of action of serum and lipoids are totally 
different. The inhibition of trypsin by serum is greatest 
at the commencement, but diminishes. Lipoids act by initial 
stimulation, and subsequent destruction.
(iii) Chloroform treated sera remain antitryptic.
(c) Protein theory. This only can be reconciled with the 
following evidence:
(i) Crystallised albumin is antitryptic.
(ii) The protein fraction of serum is antitryptic.
(iii) The proteins are the only substances in serum affected 
by heat.
(iv) The recovery of trypsin from inhibition is readily 
understood if the substance by which tryosin'is adsorbed is 
protein, since the protein is gradually split up and trypsin 
released; this recovery would be difficult: to understand if
i the adsorbing substance were other than a substrate of trypsin.
The mode of action of the antitryptic substance whatever be its 
lure is clearly one of adsorption. This is proved by the kinetic 
,fttionship between serum and trypsin as worked out by Hedin.
I This mechanism explains the anomaly pointed out by Beaton, since 
.increased antitryptic index need not be associated with an increased 
isentration of serum albumin*, it need only be associated with an 
pease in surface of the colloidal albumin, which is co-'natible with a 
pease in the actual amount of albumin.
!) The antibody theory of serum antitrypsin is essentially a
I chemicallyiation of the protein theory, stated in the/obscure language of
Kino logy.
; Immunological antibodies resemble serum antitrypsin in 
; (a) both being normally present in association with the protein 
\ of serum*
• (b) both neutralising certain substances by the same mechanism - 
f. adsorption.
..They differ, however in that -
\ (a) True antibodies are associated with globulin, antitrypsin 
I with albumin (chiefly).
 ^ (b) True antibodies can be Increased almost indefinitely by
f injections of antigen; antitrypsin only slightly responds to 
I injections of trypsin.
r.
r
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Illustrating recovery of trypsin from inhi iting action 
of egg albumin.
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Showing partial destruction by CHCl^ of inhibitory 
action of egg albumin.
Showing recovery of Inhibited trynsin until activity 
is greater than ti at of uninhibited tryosin#
—Pin, a..
Showing how free acid produced by inhibited tryusin 
ultimately equals amount formed by uninhibited trypsin.
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Showing how inhibited trypsin ultlrately forns 
more formol acid than uninhibited trypsin.
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PIG. 6-
Recovery of Inhibited trypsin is incomplete in this 
case: the serum was obtained from a guinea-pig w>ich had 
recently had a large injection of trypsin.
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Experiment is samo as in Fig* fopmol qcid only 
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Showing accelerated recovery of inhi bitad trypsin
in presence of gelatin. The dotted part of the curves 
is hypothetical, as no estimation of acidity wa=» made during 
that interval.
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Shoving the ;jame relation between the free acid formed by 
inhibited and by uninhibited *n as in Fig. i,
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Shoring same relation between forswol acid formed by inhibited 
and uninhibited try in as in Fig. 5“
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Illustrating the kinetics of recovery of trypsin 
from inhibition. This figure suggests a division of the 
curves into four trypsin zones.
Zone 1* 5 Trypsin. Here there is no recovery
from the inhibiting action of 10%  serum.
Zone 2. 5%• 20% : inhibition is initially complete to
partial, and recovery is partial to complete.
Zone 3* Trypsin 2o%- 25% (dotted lines); inhibition is
initially small, and recovery is complete.
Zone U: Trypsin over 2b0/ . Inhibition is absent.
No experiments v ere actually carried out in Zones 3 I4., which are
jorely strongly suggested by the character of the Zones 2 & 3, and b^
fact established, on other occasions that concentrated try-sin 
8uccQssfully resists the Inhibiting action of serum.
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Illustrating
(1) that degree of Inhibiting is a TogarifcVmic 
fumetion of amount of inhibiting serum fthus suggesting 
that inhibition is an adsorption nhenomenon).
f.2) inabil ity of . orur. to achieve 100$ ir. I fcioa 
of trypsin, the reasons for hi ah are discussed in the text,
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Shewing that samples of trypsin equally inhibited by weak 
serum nay not be equally Inhibited by stronger seru-.
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Here weak serum Inhibits tie trwo samples differently, 
the difference diminishing as the rerum becomes strong-ir.
"13.
Showing a rise in index immediately or shortly after each 
injection of trypsin. The guinea-pig was iled daily without 
d finite relationship to the time of feeding, this leading to 
apparently spontaneous fluctuations in the curve,
't^ IH . 1V
After the first in.ioction the index rises and regains high
throughout the experiment.
*15\
Both injections aro definitely associated with a 
subsequent rise in index. The very large first injection 
produced a preliminary fall.
Showing that sodium oleate initially stimulates and 
ultimately depresses trypsin, whereas serum exerts an initial
inhibition from which trynsin progressively recovers.
These curves were obtained by plotting the course of 
digestion of the following four tubes, the usual Sorensen!s 
technique being folloved.
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I’he following Fig# ^6 shows relationship between degree 
of dispersion of.a fixed volume of a substance the t^tal 
surface presented for adsorption.
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APPENDIX.
ON TliA 0  JCURrttiNCja OP1 OTlihR THAN CAiiBnM lC L lkftA G jiS  ( CGkH )
IN THiii P ltO T nlN  MOLECULE .
In examining the meaning of the Dastre phenomenon,. the newer 
knowledge of the heterogeneous nature of trypsin and erepsin 
was ignored in order to avoid complication of the issue; in any 
case it still remains true that the proteolytic enzymes can 
broadly be divided into two groups - one attacking chiefly the 
protein molecules, and the larger polypeptides, and the other 
attacking mainly the smaller.molecules.
The conclusion that serum oehaved as an anti-tryptase was 
an expression of the fact that one phase only of the action of 
trypsin was inhioited. If the action of trypsin on a protein 
be examined by Sorensen’s method it v/ill be found that at the 
commencement free acid production predominates over formal acid, 
but that ultimately formol acid overtakes free acid.
Since the first action of trypsin is to hydrolise the 
protein molecule into polypeptides, the predominance of free acid 
formation may be correlated with the power to attack the protein 
molecule, while predominance of formal acid may denote hydrolysis 
of the earlier products of activity.
is
This correlation, which has hitherto been assumed,/oorne 
out by the oehaviour of pepsin, whose hydrolysis of proteins 
to the peptone stage only is correlated with the preponderance 
of free over formol acid throughout the period of digestion.
Strictly speaking however it cannot be assumed that free 
acid formation is the..sole activity of the enzyme attacking the 
protein molecule since, as Haldane points out (1950) the 
specificity of the proteolytic enzymes is not aosolutely fixed, 
each enzyme oeing capable of effecting a number of allied 
hydrolytic reactions.
Consequently the inhioition of free acid formation does not 
necessarily prove the inhibition of proteinase, but denotes the 
suppression of one form of activity of proteinase.
ii.
The significance of free acid formation*
PitHiiner pointed out (1908) that in addition to the carbamic 
linkage COkH there may be present in the protein molecule
1. The arginine linkage CH -NH-C
^NH-CO
2. The diketopiperazine linkage R-C 0-R
x C0-hH^
3. Among the oxy-acids, the ether, ester, and anhydride
linkages.
He did not consider it proved that such linkages did exist, 
however, and even quite recently Granacher (1929), who believes 
the ester linkage highly probable in proteins, considers definite 
proof of this wanting.
It seems to me that the formation of free acid during 
hydrolysis of serum proteins is proof of the existence of 
linkages other than COkH. Glearly the hydrolysis of -COHH- 
by forming carboxylic and amino groups, cannot increase free 
acidity, but will increase formol acidity.
Tne linkages whose hydrolysis could produce free acid are 
ester and thio-ester, since on hydrolysis ester produces 
carboxyl and hydroxyl, and thio-ester produces carboxyl and 
sulphhydril. Thio-ester is an unlikely linkage, since the 
only sulphur amino-acid in the protein molecule is present as 
cystine, and not as the mercaptan cysteine.
Since hydrolysis of esters is usually the function of 
special enzymes (lipase and phosphates) it is necessary to 
eliminate the possibility of free acid formation being due to 
them •
In my own experiments this can readily be done, since
(1) The commercial trypsin used was kept in the ice chest, 
and at a pH of 2, which is destructive of lipase, iven if lipase 
were present in the trypsin, and were responsiole for free acidity 
by action on serum fats, the action would have been greater
on unheated serum than on heated, since guinea-pig serum possesses 
a very active lipase (1930).
(2) The action of phosphatase can oe eliminated if the
90
amount of availaole pnosphate* in serum be considered. On the 
oasis for the figure for human serum (0.005 phosphorus) the 
maximum amount of free phosphoric acid ootainaole from .2 cc 
of a 10% solution of serum (the amount used in my titrations) 
is equivalent to .01 cc -^ tfo NaOH - a negligible value within 
the range of error of the experiments. That the function of pepsir 
is to nydrolyse linkages other than COHH is proved by the large 
proportion of free acid to the total acid developed during 
hydrolysis of proteins: out there is more definite evidence of 
this function.
Thus Harris shewed (1923) that SH groups were unmarked 
during peptic digestion, and Abderhalden & Schwab (1930) showed 
that pepsin completely hydrolysed di-leucyl-thyroxine, although 
one of the leucine molecules was combined as an ester.
j
Haldane suggests that in the latter instance the ester linkage 
was split oy a lipase present, but it is unlikely that lipase 
would act at the optimum pH of pepsin.
It is very significant that in a list of 53 polypeptides, 
of which 24 were hydrolysed by trypsin and 29 were not, all 
those containing tyrosine (four) cystine (£wo) and isoserine 
(one), i.e. the only amino acids with potentialities for other 
than CONH linkages, were in the hydrolysable group (Plummer,
1908).
This would do no coincidence if hydrolysis of other than 
COHH linkages were a special function of trypsin or of one of 
its constituents.
There is no mention however as to whether free acid 
increased during any of the hydrolyses, and therefore the nature 
of the linkages is not proved.
Serum antitrypsin as a resistance of the non carbamic 
linkages of serum proteins.
If free acid formation is admitted the result of hydrolysis 
of other than CONH linkages, then the inhioition by serum 
proteins of free acid formation must be due to a special
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resistance of these other linkages, a resistance which is 
overcome Dy heating at 70°0 for ^ hr.
This effect of heat is not due to coagulation, since serum 
heated with buffer at pH 8 became only faintly turoid, yet lost 
its antitryptic action.
Possibly the molecules adjoining tne special linkages are 
stereochemically antagonistic to the action of trypsin, but are 
sterically altered by heat. Such stereochemical specificity 
is met with throughout enzyme reactions, one of the simplest 
examples being the resistance of glycine d leucine, but not 
glycine 1 leucine to hydrolysis oy yeast erepsin (Abderhalden 
& Handov/sky 1921). That proteins can become less hydrolysable by 
trypsin as a result of stereochemical alteration has been shown 
by Dakin & Dudley (1913) who found that partial raceraisation of 
casein by alkali (the rotary power falling to 60%) made it 
resistant to trypsin: Lin Wu k Chen (1928) however found that 
resistance, although marked, was not complete.
But serum not only resists trypsin; it adsorbs it also, 
rendering it unavailable for other substrates present.
The complete mechanism of serum antitrypsin might therefore 
be conceived as
(a) An adsorption, at the ester and other non carbamic 
linkages, of those constituents of trypsin capable of attacking 
them
(b) A resistance to hydrolysis on account of neighbouring 
stereochemical influences.
(c) A breakdown of the resistance, whether through 
stereochemical changes or other causes.
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